| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |



*
Department of Internal Medicine, School of Medicine, Keio University,
Tokyo, Japan
Department of Nephrology, Saitama Medical School, Saitama,
Japan
Department of Medical Engineering and Systems Cardiology, Kawasaki Medical
School, Okayama, Japan.
Correspondence to Dr. Takao Saruta, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. Phone: +81 3 3353 1211, extension 2312; Fax: +81 3 3359 2745; E-mail: saruta{at}mc.med.keio.ac.jp
Abstract. The present study examined the role of intrarenal
bradykinin in angiotensin-converting enzyme inhibitor (ACEI)-induced dilation
of renal afferent (AFF) and efferent arterioles (EFF) in vivo, and
further evaluated whether ACEI-stimulated bradykinin activity differed in
superficial (SP) and juxtamedullary nephrons (JM). Arterioles of canine
kidneys were visualized with an intravital charge-coupled device camera
microscope. E4177 (an angiotensin receptor antagonist, 30 µg/kg) dilated
AFF and EFF in SP (15 ± 3% and 19 ± 5%) and JM (15 ± 3%
and 18 ± 4%). Subsequently, cilazaprilat (30 µg/kg) caused further
dilation of both AFF (29 ± 4%) and EFF (36 ± 4%) in JM, whereas
in SP it dilated only EFF (29 ± 3%). Similarly, in the presence of
E4177, cilazaprilat caused further increases in sodium excretion. This
cilazaprilat-induced vasodilation and natriuresis was abolished by a
bradykinin antagonist
(N
-adamantaneacetyl-D-Arg-[Hyp3,Thi5,8,D-Phe7]-bradykinin).
In parallel with these results, cilazaprilat increased renal bradykinin
content, more greatly in the medulla than in the cortex (5.7 ± 0.4
versus 4.6 ± 0.1 ng/g). Similarly, cilazaprilat elicited
greater bradykinin-dependent increases of nitrite/nitrate in the medulla. In
conclusion, zonal heterogeneity in renal bradykinin/nitric oxide levels and
segmental differences in reactivity to bradykinin contribute to the diverse
responsiveness of renal AFF and EFF to ACEI. ACEI-enhanced kinin action would
participate in the amelioration of glomerular hemodynamics and renal sodium
excretion by ACEI.
This article has been cited by other articles:
![]() |
N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta Ca2+ Channel Subtypes and Pharmacology in the Kidney Circ. Res., February 16, 2007; 100(3): 342 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force Members, J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: The Task Force on ACE-inhibitors of the European Society of Cardiology Eur. Heart J., August 2, 2004; 25(16): 1454 - 1470. [Full Text] [PDF] |
||||
![]() |
X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement Hypertension, March 1, 2004; 43(3): 533 - 535. [Full Text] [PDF] |
||||
![]() |
H. Matsuda, K. Hayashi, S. Wakino, E. Kubota, M. Honda, H. Tokuyama, I. Takamatsu, S. Tatematsu, and T. Saruta Role of Endothelium-Derived Hyperpolarizing Factor in ACE Inhibitor-Induced Renal Vasodilation in Vivo Hypertension, March 1, 2004; 43(3): 603 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tokuyama, K. Hayashi, H. Matsuda, E. Kubota, M. Honda, K. Okubo, I. Takamatsu, S. Tatematsu, Y. Ozawa, S. Wakino, et al. Differential Regulation of Elevated Renal Angiotensin II in Chronic Renal Ischemia Hypertension, July 1, 2002; 40(1): 34 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamamoto, Y. Tomura, H. Tanaka, and F. Kajiya In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats Am J Physiol Renal Physiol, September 1, 2001; 281(3): F571 - F577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C. Lansang and N. K Hollenberg ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 119 - 124. [PDF] |
||||
![]() |
H. Tokuyama, K. Hayashi, H. Matsuda, E. Kubota, M. Honda, K. Okubo, Y. Ozawa, and T. Saruta Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia Am J Physiol Renal Physiol, May 1, 2002; 282(5): F859 - F865. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673